Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11178)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Khan FZ, Perumpail RB, Wong RJ, Ahmed A. Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. World J Hepatol 2015; 7(18): 2155-2161 [PMID: 26328027 DOI: 10.4254/wjh.v7.i18.2155] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i18/2155.htm |
| Number | Citing Articles |
| 1 |
Shangfu Li, Dan Gao, Yuyang Jiang. Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma. Metabolites 2019; 9(2): 36 doi: 10.3390/metabo9020036
|
| 2 |
Xing-Yu Chen, Cong Wang, Yi-Zhou Huang, Li-Li Zhang. Nonalcoholic fatty liver disease shows significant sex dimorphism. World Journal of Clinical Cases 2022; 10(5): 1457-1472 doi: 10.12998/wjcc.v10.i5.1457
|
| 3 |
Minoru Tomizawa, Fuminobu Shinozaki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige. 2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells. Oncology Letters 2017; 13(2): 800 doi: 10.3892/ol.2016.5510
|
| 4 |
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
|
| 5 |
|
| 6 |
Subrat K. Acharya, Sawan Bopanna. Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?. Journal of Clinical and Experimental Hepatology 2020; 10(5): 518 doi: 10.1016/j.jceh.2020.04.004
|
| 7 |
Eliana Ferroni, Stefano Guzzinati, Alessandra Andreotti, Susanna Baracco, Maddalena Baracco, Emanuela Bovo, Eva Carpin, Antonella Dal Cin, Alessandra Greco, Annarita Fiore, Laura Memo, Daniele Monetti, Silvia Rizzato, Jessica Elisabeth Stocco, Carmen Stocco, Sara Zamberlan, Manuel Zorzi. Cancer incidence in immigrants by geographical area of origin: data from the Veneto Tumour Registry, Northeastern Italy. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1372271
|
| 8 |
Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, Mary E. Rinella, Rohit Loomba, Stephen H. Caldwell, Curtis K. Argo. Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Alimentary Pharmacology & Therapeutics 2018; 48(7): 696 doi: 10.1111/apt.14937
|
| 9 |
Brian I. Carr, Gianluigi Giannelli, Vito Guerra, Edoardo G Giannini, Fabio Farinati, Gian Ludovico Rapaccini, Maria Di Marco, Marco Zoli, Eugenio Caturelli, Alberto Masotto, Roberto Virdone, Rodolfo Sacco, Franco Trevisani. Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients. The International Journal of Biological Markers 2018; 33(4): 423 doi: 10.1177/1724600818776838
|
| 10 |
William P. Esler, Kendra K. Bence. Metabolic Targets in Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2019; 8(2): 247 doi: 10.1016/j.jcmgh.2019.04.007
|
| 11 |
Mahitha Lampimukhi, Tabarak Qassim, Rakshaya Venu, Nivedita Pakhala, Suchita Mylavarapu, Tharindu Perera, Beeran S Sathar, Arun Nair. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma. Cureus 2023; doi: 10.7759/cureus.49429
|
| 12 |
K. Rajender Reddy, Dale McLerran, Tracey Marsh, Neehar Parikh, Lewis R. Roberts, Myron Schwartz, Mindie H. Nguyen, Alex Befeler, Stephanie Page-Lester, Runlong Tang, Sudhir Srivastava, Jo Ann Rinaudo, Ziding Feng, Jorge A. Marrero. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. Gastroenterology 2023; 165(4): 1053 doi: 10.1053/j.gastro.2023.06.027
|
| 13 |
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi. Oxidative Stress in Non-Alcoholic Fatty Liver Disease. Livers 2022; 2(1): 30 doi: 10.3390/livers2010003
|
| 14 |
|
| 15 |
David H. Van Thiel, Salamah Mohammad Alwahsh, Giuliano Ramadori. Hepatocellular Carcinoma. 2016; : 287 doi: 10.1007/978-3-319-34214-6_19
|
| 16 |
Chiara Lopane, Pasquale Agosti, Isabella Gigante, Carlo Sabbà, Antonio Mazzocca. Implications of the lysophosphatidic acid signaling axis in liver cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(1): 277 doi: 10.1016/j.bbcan.2017.06.002
|
| 17 |
Yuzhu Zhang, Yurou Gao, Qian S. Liu, Qunfang Zhou, Guibin Jiang. Chemical contaminants in blood and their implications in chronic diseases. Journal of Hazardous Materials 2024; 466: 133511 doi: 10.1016/j.jhazmat.2024.133511
|
| 18 |
Xu Li, Xiaocong Wang, Pujun Gao. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5202684
|
| 19 |
Tony S. Brar, Eric Hilgenfeldt, Consuelo Soldevila-Pico. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 1 doi: 10.1007/978-3-319-68082-8_1
|
| 20 |
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
|
| 21 |
Evanthia Tourkochristou, Athanasia Mouzaki, Christos Triantos. Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression. International Journal of Molecular Sciences 2023; 24(9): 8288 doi: 10.3390/ijms24098288
|
| 22 |
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M. Serra Cusidó, Alba Jiménez-Masip, Sven M. Francque, Frank Tacke, Beatriz Minguez, Juan M. Pericàs. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2024; 22(9): 1774 doi: 10.1016/j.cgh.2024.03.028
|
| 23 |
Luca Quagliata. Clinical, Histological, and Molecular Classification of Hepatocellular Carcinoma: How Do They Get Along?. EMJ Hepatology 2016; : 58 doi: 10.33590/emjhepatol/10313752
|
| 24 |
|
| 25 |
|
| 26 |
Encheng Yang, Xiao Li, Ningyi Jin. The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment. Cancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0351-0
|
| 27 |
Kelly E Mercer, Casey F Pulliam, Kim B. Pedersen, Leah Hennings, Martin JJ Ronis. Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid diet. Experimental Biology and Medicine 2017; 242(6): 635 doi: 10.1177/1535370216685436
|
| 28 |
Laurence J Britton, V Nathan Subramaniam, Darrell HG Crawford. Iron and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(36): 8112-8122 doi: 10.3748/wjg.v22.i36.8112
|
| 29 |
Neeta B. Amin, Santos Carvajal-Gonzalez, Julie Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin. Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis. Science Translational Medicine 2019; 11(520) doi: 10.1126/scitranslmed.aav9701
|
| 30 |
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. Biomedicines 2021; 9(11): 1524 doi: 10.3390/biomedicines9111524
|
| 31 |
Qing Ye, Bao-Xin Qian, Wei-Li Yin, Feng-Mei Wang, Tao Han, Pavel Strnad. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls. PLOS ONE 2016; 11(9): e0163423 doi: 10.1371/journal.pone.0163423
|
| 32 |
Chang-Nim Im. Past, present, and emerging roles of mitochondrial heat shock protein TRAP1 in the metabolism and regulation of cancer stem cells. Cell Stress and Chaperones 2016; 21(4): 553 doi: 10.1007/s12192-016-0687-3
|
| 33 |
Wanshui Yang, Xufen Zeng, Jessica L Petrick, Christopher J Danford, Andrea A Florio, Bing Lu, Hongmei Nan, Jiantao Ma, Liang Wang, Hongmei Zeng, Staci L Sudenga, Peter T Campbell, Edward Giovannucci, Katherine A McGlynn, Xuehong Zhang. Body Mass Index Trajectories, Weight Gain, and Risks of Liver and Biliary Tract Cancers. JNCI Cancer Spectrum 2022; 6(4) doi: 10.1093/jncics/pkac056
|
| 34 |
John D Groopman. Environmental health in the biology century: Transitions from population to personalized prevention. Experimental Biology and Medicine 2019; 244(9): 728 doi: 10.1177/1535370219837903
|
| 35 |
|
| 36 |
Laurence Britton, Lesley-Anne Jaskowski, Kim Bridle, Eriza Secondes, Daniel Wallace, Nishreen Santrampurwala, Janske Reiling, Gregory Miller, Salvatore Mangiafico, Sofianos Andrikopoulos, V. Nathan Subramaniam, Darrell Crawford. Ferroportin Expression in Adipocytes Does Not Contribute to Iron Homeostasis or Metabolic Responses to a High Calorie Diet. Cellular and Molecular Gastroenterology and Hepatology 2018; 5(3): 319 doi: 10.1016/j.jcmgh.2018.01.005
|
| 37 |
Yuki Hamada, Eiichi Hirano. Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis. 2023; doi: 10.5772/intechopen.107221
|
| 38 |
Mayuko Ichimura, Miki Masuzumi, Miku Kawase, Mika Sakaki, Shizuka Tamaru, Yasuo Nagata, Kazunari Tanaka, Kazuhito Suruga, Koichi Tsuneyama, Satoru Matsuda, Katsuhisa Omagari. A diet-induced Sprague–Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis. The Journal of Nutritional Biochemistry 2017; 40: 62 doi: 10.1016/j.jnutbio.2016.10.007
|
| 39 |
Vlad Ratziu, Arun Sanyal, Stephen A. Harrison, Vincent Wai‐Sun Wong, Sven Francque, Zachary Goodman, Guruprasad P. Aithal, Kris V. Kowdley, Star Seyedkazemi, Laurent Fischer, Rohit Loomba, Manal F. Abdelmalek, Frank Tacke. Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study. Hepatology 2020; 72(3): 892 doi: 10.1002/hep.31108
|
| 40 |
Moustafa A. Sakr, Mahmood A. Al-Azzawi, Anis Anis, Amal A. Abd El-Aziz, Mohamed E. Ebeid, Mahmoud A. Shokeer, Aysam fayed. The correlation between P53 and COX-2 expression and the pathological alteration in hepatocellular carcinoma. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00230-y
|
| 41 |
Omar Massoud, Michael Charlton. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clinics in Liver Disease 2018; 22(1): 201 doi: 10.1016/j.cld.2017.08.014
|
| 42 |
Yvonne Huber, Christian Labenz, Maurice Michel, Marcus-A. Wörns, Peter R. Galle, Karel Kostev, Jörn M. Schattenberg. Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease. Deutsches Ärzteblatt international 2020; doi: 10.3238/arztebl.2020.0719
|
| 43 |
Ans Jacobs, Anne‐Sophie Warda, Jef Verbeek, David Cassiman, Pieter Spincemaille. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present. Current Protocols in Mouse Biology 2016; 6(2): 185 doi: 10.1002/cpmo.3
|
| 44 |
Salvatore Lorenzo Renne, Samantha Sarcognato, Diana Sacchi, Maria Guido, Massimo Roncalli, Luigi Terracciano, Luca Di Tommaso. Hepatocellular carcinoma: a clinical and pathological overview. Pathologica 2021; 113(3): 203 doi: 10.32074/1591-951X-295
|
| 45 |
JIN-YAN ZHANG, MING-ZHE WENG, FANG-BIN SONG, YONG-GANG XU, QI LIU, JUN-YI WU, JUN QIN, TAO JIN, JUN-MING XU. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. International Journal of Oncology 2016; 48(4): 1590 doi: 10.3892/ijo.2016.3385
|
| 46 |
Abdulrahman Mohammed Hakami, Erwa Elmakki. Nonalcoholic Steatohepatitis-Induced Hepatocellular Carcinoma. King Khalid University Journal of Health Sciences 2022; 7(1): 1 doi: 10.4103/KKUJHS.KKUJHS_1_22
|
| 47 |
Tahereh Setayesh, Steven D. Colquhoun, Yu-Jui Yvonne Wan. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma. Liver Research 2020; 4(4): 173 doi: 10.1016/j.livres.2020.11.001
|
| 48 |
Özlem Akdoğan, Ayşegül Atak Yücel, Zeynep Gök Sargin, Cemile Sönmez, Güldal Esendağli Yilmaz, Seren Özenirler. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. Journal of Clinical and Experimental Hepatology 2019; 9(1): 29 doi: 10.1016/j.jceh.2018.02.001
|
| 49 |
Paola Dongiovanni, Marica Meroni, Salvatore Petta, Miriam Longo, Anna Alisi, Giorgio Soardo, Luca Valenti, Luca Miele, Stefania Grimaudo, Grazia Pennisi, Grieco Antonio, Dario Consonni, Silvia Fargion, Anna Ludovica Fracanzani. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(10): 158765 doi: 10.1016/j.bbalip.2020.158765
|
| 50 |
Priyankar Dey, Joshua B. Kim, Chureeporn Chitchumroonchokchai, Jinhui Li, Geoffrey Y. Sasaki, Bryan D. Olmstead, Katie L. Stock, Jennifer M. Thomas-Ahner, Steven K. Clinton, Richard S. Bruno. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis. Food & Function 2019; 10(10): 6351 doi: 10.1039/C9FO01199D
|
| 51 |
Neeta B. Amin, Aditi R. Saxena, Veena Somayaji, Robert Dullea. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology. Clinical Therapeutics 2023; 45(1): 55 doi: 10.1016/j.clinthera.2022.12.008
|
| 52 |
Reham F. Amin, Amal S. El Bendary, Sherif E. Ezzat, Waleed S. Mohamed. Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 2226 doi: 10.1016/j.dsx.2019.05.030
|
| 53 |
Ge Chenxu, Xu Minxuan, Qin Yuting, Gu Tingting, Feng Jing, Lv Jinxiao, Wang Sujun, Ma Yongjie, Lou Deshuai, Li Qiang, Hu Linfeng, Nie Xuyuan, Wang Mingxing, Huang Ping, Tan Jun. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. Free Radical Biology and Medicine 2019; 134: 23 doi: 10.1016/j.freeradbiomed.2018.12.034
|
| 54 |
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
|
| 55 |
Jiayao Chen, Shuhong Kuang, Jietao Cen, Yong Zhang, Zongshan Shen, Wei Qin, Qiting Huang, Zifeng Wang, Xianling Gao, Fang Huang, Zhengmei Lin. Multiomics profiling reveals VDR as a central regulator of mesenchymal stem cell senescence with a known association with osteoporosis after high-fat diet exposure. International Journal of Oral Science 2024; 16(1) doi: 10.1038/s41368-024-00309-9
|
| 56 |
Hiba S Al-Amodi, Hala F Kamel. Altered Metabolites in Hepatocellular Carcinoma (HCC) Paving the Road for Metabolomics Signature and Biomarkers for Early Diagnosis of HCC. Cureus 2024; doi: 10.7759/cureus.71968
|
| 57 |
María Antonia Mateo-Marín, Michele Alves-Bezerra. Targeting acetyl-CoA carboxylases for the treatment of MASLD. Journal of Lipid Research 2024; 65(12): 100676 doi: 10.1016/j.jlr.2024.100676
|
| 58 |
Minqian Shen, Haifei Shi, Antimo Migliaccio. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells. PLOS ONE 2016; 11(3): e0151455 doi: 10.1371/journal.pone.0151455
|